[1]
Norton JA,Foster DS,Ito T,Jensen RT, Gastrinomas: Medical or Surgical Treatment. Endocrinology and metabolism clinics of North America. 2018 Sep; [PubMed PMID: 30098717]
[3]
Roy PK,Venzon DJ,Feigenbaum KM,Koviack PD,Bashir S,Ojeaburu JV,Gibril F,Jensen RT, Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature. Medicine. 2001 May; [PubMed PMID: 11388095]
[4]
Krampitz GW,Norton JA, Current management of the Zollinger-Ellison syndrome. Advances in surgery. 2013; [PubMed PMID: 24298844]
[5]
Gibril F,Jensen RT, Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Current gastroenterology reports. 2004 Dec; [PubMed PMID: 15527675]
[6]
Corleto VD,Annibale B,Gibril F,Angeletti S,Serrano J,Venzon DJ,Delle Fave G,Jensen RT, Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Alimentary pharmacology [PubMed PMID: 11563994]
[7]
ZOLLINGER RM,ELLISON EH, Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Annals of surgery. 1955 Oct; [PubMed PMID: 13259432]
[8]
Gastric Hypersecretory States: Investigation and Management., Phan J,Benhammou JN,Pisegna JR,, Current treatment options in gastroenterology, 2015 Dec [PubMed PMID: 26342486]
[10]
Epelboym I,Mazeh H, Zollinger-Ellison syndrome: classical considerations and current controversies. The oncologist. 2014 Jan; [PubMed PMID: 24319020]
[11]
Berna MJ,Hoffmann KM,Serrano J,Gibril F,Jensen RT, Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine. 2006 Nov; [PubMed PMID: 17108778]
[13]
Pisegna J,Holtmann G,Howden CW,Katelaris PH,Sharma P,Spechler S,Triadafilopoulos G,Tytgat G, Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Alimentary pharmacology [PubMed PMID: 15527464]
[14]
Pisegna JR, The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach. Current gastroenterology reports. 1999 Dec; [PubMed PMID: 10980995]
[15]
Roy PK,Venzon DJ,Shojamanesh H,Abou-Saif A,Peghini P,Doppman JL,Gibril F,Jensen RT, Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine. 2000 Nov; [PubMed PMID: 11144036]
[16]
Jensen RT, Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1. Journal of internal medicine. 1998 Jun; [PubMed PMID: 9681846]
[17]
McGowan CC,Cover TL,Blaser MJ, Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology. 1996 Mar; [PubMed PMID: 8608904]
[18]
Quintero E,Ohning GV,Del Rivero M,Wong HC,Walsh JH,Guth PH, Gastrin mediates the increase in gastric cell growth in uremic rats. The American journal of physiology. 1995 Apr; [PubMed PMID: 7733285]
[19]
Quintero E,Kaunitz J,Nishizaki Y,De Giorgio R,Sternini C,Guth PH, Uremia increases gastric mucosal permeability and acid back-diffusion injury in the rat. Gastroenterology. 1992 Dec; [PubMed PMID: 1451970]
[20]
Sutliff VE,Doppman JL,Gibril F,Venzon DJ,Yu F,Serrano J,Jensen RT, Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Jun; [PubMed PMID: 9196158]
[21]
Roland CL,Bian A,Mansour JC,Yopp AC,Balch GC,Sharma R,Xie XJ,Schwarz RE, Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. Journal of surgical oncology. 2012 May; [PubMed PMID: 22006521]